Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 923,675 | 569,546 | 468,041 | 232,256 | 103,670 |
| Operating Income | -923,675 | -569,546 | -468,041 | -232,256 | -103,670 |
| Interest Expense | 0 | 0 | 0 | 2 | 7 |
| Other Income | 157,047 | 105,619 | 65,775 | 8,773 | 3,600 |
| Pre-tax Income | -766,628 | -463,927 | -402,266 | -223,485 | -100,077 |
| Net Income Continuous | -766,628 | -463,927 | -402,266 | -223,485 | -100,077 |
| Net Income | $-766,628 | $-463,927 | $-402,266 | $-223,485 | $-100,077 |
| EPS Basic Total Ops | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| EPS Basic Continuous Ops | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| EPS Diluted Total Ops | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| EPS Diluted Continuous Ops | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 |
| EPS Diluted Before Non-Recurring Items | -5.63 | -3.80 | -4.14 | -3.09 | -1.93 |
| EBITDA(a) | $-913,249 | $-592,405 | $-492,645 | $-223,750 | $-98,807 |